Find an Alzheimer's clinical trial

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Search title, drug, condition or sponsor

Recruiting

Exact registry status

Phase

Intervention class

Study type

Country

Results per page

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 7,126–7,150 of 7,816 matching trials · page 286 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial	Phase	Status	Enrolled	Sponsor	Last updated
A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD) NCT01662882 florbetapir (18F) Runs in: Japan · 2 sites	PHASE2\|PHASE3 other	COMPLETED	48	Avid Radiopharmaceuticals INDUSTRY	2013-09-19
Effects of Exercise and Cognitive Training on Cognitive Function in Older Adults NCT01038726 Exercise Training; Cognitive Training; Flexibility Training; Educat... Runs in: United States · 1 site	NA other	COMPLETED	108	The Cleveland Clinic OTHER	2013-09-18
Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease NCT01082965 Donepezil; Placebo Runs in: United States · 8 sites	NA symptomatic-cholinergic	TERMINATED	18	Pfizer INDUSTRY	2013-09-12
Zydena on Cognitive Function of Alzheimer's Disease Patients NCT01940952 Zydena (Udenafil) 50mg + Donepezil 5mg or 10mg; Placebo + Donepezil... Runs in: South Korea · 1 site	PHASE3 symptomatic-cholinergic	UNKNOWN	210	Samsung Medical Center OTHER	2013-09-12
A Study to Tailor Advance Directives NCT00121004 Advance Directive Selection Runs in: United States · 1 site	NA other	COMPLETED	100	University of Chicago OTHER	2013-09-05
"Pilot Study of Armodafinil in Patients With Dementia With Lewy Bodies" NCT01023672 Armodafinil Runs in: United States · 1 site	PHASE4 other	COMPLETED	20	Mayo Clinic OTHER	2013-09-05
Multiple Ascending Dose Study of TC-5619 in Healthy Elderly Subjects and Subjects With Alzheimer's Disease NCT01254448 TC-5619; Placebo Runs in: United States · 10 sites	PHASE1 other	COMPLETED	38	Targacept Inc. INDUSTRY	2013-09-04
Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Subjects and an Elderly Cohort NCT01294540 Drug: E2609; Placebo Runs in: United States · 1 site	PHASE1 other	COMPLETED	73	Eisai Inc. INDUSTRY	2013-08-29
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44 NCT00948766 Rivastigmine 4.6 mg/24 h (5 cm^2); Rivastigmine 9.5 mg/24 h (10 cm^... Runs in: Puerto Rico; United States · 95 sites	PHASE4 symptomatic-cholinergic	COMPLETED	716	Novartis INDUSTRY	2013-08-28
Efficacy Study of Cognitive Intervention in Amnestic Mild Cognitive Impairment NCT01358955 group cognitive intervention; Home-based cognitive intervention Runs in: South Korea · 18 sites	NA other	COMPLETED	293	Inha University Hospital OTHER	2013-08-28
The Use of Galantamine (Reminyl ER) in Patients With MIXed Dementia: Effects on Cognition and Quality of Life NCT00814658 Galantamine; Nimodipine; Placebo	PHASE4 symptomatic-cholinergic	COMPLETED	22	Janssen-Cilag Farmaceutica Ltda. INDUSTRY	2013-08-26
Comparing Delivery Methods of Cognitive Behavioral Therapy for Depressed African-American Dementia Caregivers NCT00769769 Psychotherapy; Psychotherapy Runs in: United States · 1 site	PHASE3 other	COMPLETED	106	Robert L. Glueckauf OTHER	2013-08-23
Impact of Transcranial Direct Current Stimulation on Language Functions in Mild Cognitive Impairment NCT01771211 tDCS Runs in: Germany · 1 site	NA other	COMPLETED	18	Charite University, Berlin, Germany OTHER	2013-08-22
The Impact of Pharmacological and Electric Modulation of NMDA Pathway on the Cognitive Flexibility and Volitional Movement Preparation in Patients With Parkinson's Disease NCT01785628 Sarcosine Capsule; Placebo Capsule Runs in: Taiwan · 1 site	NA symptomatic-cholinergic	COMPLETED	30	China Medical University Hospital OTHER	2013-08-22
The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease NCT01921972 Galantamine CR; Memantine; Placebo	PHASE4 symptomatic-cholinergic	COMPLETED	232	Charite University, Berlin, Germany OTHER	2013-08-14
Telephone-Based Support for Caregivers of Patients With Dementia NCT00052104 Cognitive-Behavioral Family Systems Intervention Runs in: United States · 1 site	PHASE2\|PHASE3 other	COMPLETED	85	Rhode Island Hospital OTHER	2013-08-09
A Study to Show That the Change of Attention Measure is Correlated With the Changes of Caregiver's Burden After Treatment With Galantamine in Patients With Alzheimer's Disease NCT01734395 Galantamine	NA symptomatic-cholinergic	COMPLETED	1,882	Janssen Korea, Ltd., Korea INDUSTRY	2013-08-05
Evaluation of the Neuroinflammation Pattern of BAY85-8102 F-18, DPA-714 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of F 18, DPA-714 in Healthy Volunteers NCT01009359 F-18 DPA-714 (BAY85-8102); F-18 DPA-714 (BAY85-8102); F-18 DPA-714 ... Runs in: Finland; Netherlands · 2 sites	PHASE1 other	COMPLETED	22	Bayer INDUSTRY	2013-07-31
Clozapine IM and Aggression in Schizophrenic Patients NCT00189995 clozapine; haloperidol Runs in: Israel · 2 sites	PHASE3 other	WITHDRAWN	0	Beersheva Mental Health Center OTHER_GOV	2013-07-24
A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808 NCT01723488 [F18] T808 Runs in: United States · 2 sites	EARLY_PHASE1 other	TERMINATED	12	Avid Radiopharmaceuticals INDUSTRY	2013-07-19
A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807 NCT01733355 [F18] T807 Runs in: United States · 2 sites	EARLY_PHASE1 other	TERMINATED	11	Avid Radiopharmaceuticals INDUSTRY	2013-07-19
Multistimulation Group Therapy for Alzheimer's Disease NCT01893398 Multidimensional stimulation group therapy Runs in: Italy · 1 site	NA other	COMPLETED	60	Fondazione Don Carlo Gnocchi ETS OTHER	2013-07-09
Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease NCT00359944 AC-3933; AC-3933; Sugar Pill Runs in: United States · 34 sites	PHASE2 other	COMPLETED	171	Sumitomo Pharma America, Inc. INDUSTRY	2013-07-02
Positron Emission Tomography (PET) Amyloid Imaging of the Brain in Healthy Young Adult Subjects NCT01265394 [18F] Flutemetamol Runs in: United States · 1 site	PHASE3 other	COMPLETED	218	GE Healthcare INDUSTRY	2013-07-02
Repetitive Transcranial Magnetic Stimulation for Apathy Treatment in Alzheimer's Disease NCT01885806 Magnetic Stimulator Magstim Rapid 2; Sham Magnetic Stimulator Runs in: Brazil · 2 sites	PHASE2 other	UNKNOWN	40	Federal University of Minas Gerais OTHER	2013-06-25

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry: ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file: 7,816
Source file: trials.csv (3.8 MB, 7816 rows)
Basis: Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024 · score 88/100
Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial The Lancet. Neurology, 2026 · score 86/100
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial Lancet (London, England), 2021 · score 86/100
Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease Journal of Alzheimer's disease : JAD, 2026 · score 86/100
Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial EBioMedicine, 2024 · score 85/100

All 162 studies on Clinical trials →